Suppressive effects of cyclosporin A and FK-506 on superoxide generation in human polymorphonuclear leukocytes primed by tumor necrosis factor α

Journal of Investigative Dermatology

Volumn 115, Issue 6, 2000, Pages 986-989

  Goto, Yasushi ^a   Kono, Takeshi ^a   Ishii, Masamitsu ^a   Sato, Eisuke F ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CBL; Priming

Indexed keywords

CYCLOSPORIN A; FORMYLMETHIONYLLEUCYLPHENYLALANINE; SUPEROXIDE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0034524645     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00181.x     Document Type: Article

References (26)

1. Role of tyrosyl phosphorylation in neutrophil priming by tumor necrosis factor-α and granulocyte colony stimulating factor
2. Differential effect of cyclosporine A on respiratory burst by several types of human leukocytic cells
3. Pharmacology of cyclosporine (Sandimmune) V. Pharmacological effects on immune function: In vitro studies
4. Effect of immunosuppressive regimens on neutrophil chemotaxis
5. FK-506 and cyclosporin A: Selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation
6. Neutrophil priming: The cellular signals that say 'amber' but not 'green'
7. Cyclosporine and human neutrophil function
8. Activation of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: The role of immunomodulating cytokines
9. Immunomodulating cytokines in atopic dermatitis and psoriasis: Production of tumour necrosis factor and lymphotoxins by mononuclear cells in vitro
10. Effect of cydosporine A on human neutrophil and monocyte function
11. Inhibition of cytokine gene expression in mouse skin by subcutaneous injection of cyclosporine
12. Effects of cyclosporine A and FK506 on ischemia/reperfusion-induced neutrophil infiltration in the cat
13. Neutrophils in human diseases
14. Agonist-specific tyrosine phosphorylation of Cbl in human neurrophils
15. Arachidonic acid metabolism in human neutrophils: Lack of effect of cyclosporine A
16. Cyclosporine A inhibits polymorphonuclear leukocyte chemotaxis in viva
17. Human oral neutrophils: Isolation and characterization
18. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis
19. Lack of opioid peptides, morphine and naloxan on superoxide formation in human neutrophils and HL-60 leukemic cells
20. Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocytes signal transduction
21. FK-506 for liver, kidney and pancreas transplantation
22. Suppression of superoxide production from polymorphonuclear leukocytes by cyclosporine in ischemia-reperfusion of the liver
23. Human polymorphonuclear leukocyte interaction with cyclosporine A
24. Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations
25. Differential inhibition of human neutrophil activation by cyclosporin A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation
26. Isolation of human salivary polymorphonuclear leucocytes and their stimulation-coupled responses